LCG
ANIP icon

Lisanti Capital Growth’s ANI Pharmaceuticals ANIP Stock Holding History

Lisanti Capital Growth’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,379
Closed -$2.4M – 107
2025
Q4 		$2.4M Sell
30,379
-52,175
-63% -$4.52M 0.57% 75
2025
Q3 		$7.56M Sell
82,554
-12,611
-13% -$1.03M 1.85% 5
2025
Q2 		$6.21M Sell
95,165
-10,260
-10% -$668K 1.72% 12
2025
Q1 		$7.06M Buy
105,425
+78,515
+292% +$4.69M 2.1% 3
2024
Q4 		$1.49M Buy
26,910
+11,990
+80% +$688K 0.36% 91
2024
Q3 		$890K Sell
14,920
-36,185
-71% -$2.21M 0.23% 107
2024
Q2 		$3.25M Buy
51,105
+19,020
+59% +$1.23M 0.78% 62
2024
Q1 		$2.22M Buy
+32,085
New +$1.94M 0.54% 73

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Lisanti Capital Growth's ANIP Position: Q1 2026 in Review

Lisanti Capital Growth sold out of ANI Pharmaceuticals (ANIP) in Q1 2026, closing a stake of 30,379 shares — an estimated $2.4M sold.

Lisanti Capital Growth first reported a position in ANIP in Q1 2024 and held it in 8 quarters. The position peaked at $7.56M in Q3 2025. 281 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Lisanti Capital Growth reported no remaining ANI Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Lisanti Capital Growth sold 30,379 ANI Pharmaceuticals shares in Q1 2026, an estimated $2.4M.
  • Lisanti Capital Growth first reported a position in ANI Pharmaceuticals in Q1 2024 and held it in 8 quarters.
  • Lisanti Capital Growth's ANI Pharmaceuticals position peaked at $7.56M in Q3 2025.
  • 281 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Lisanti Capital Growth's 13F filing for Q1 2026, filed 7 May 2026.